Literature DB >> 4085589

ABH secretor status in cystic fibrosis--a negative report.

E F Haponik, D Stokes, B J Rosenstein, W T Hughes.   

Abstract

In adults, the inability to secrete ABH blood group substances in water-soluble form has been recognized as an independent risk factor for the development of chronic obstructive lung disease. We studied 50 patients (mean age 12.1 years) with cystic fibrosis and identified 33 ABH secretors and 17 non-secretors. There was no correlation between secretor status and clinical status, spirometry measurements, salivary and serum lysozyme levels or rates of respiratory tract colonization with P. aeruginosa and S. aureus.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4085589

Source DB:  PubMed          Journal:  Eur J Respir Dis        ISSN: 0106-4339


  3 in total

1.  Abnormal fucosylation of-ileal mucus in cystic fibrosis: II. A histochemical study using monoclonal antibodies to fucosyl oligosaccharides.

Authors:  A King; M McLeish; S Thiru
Journal:  J Clin Pathol       Date:  1990-12       Impact factor: 3.411

2.  Hypertonic saline solutions do not influence the solubility of sputum from secretor and non-secretor cystic fibrosis patients.

Authors:  Marcelo A I Barboza; Cinara C Brandão de Mattos; Ana Iara C Ferreira; Paulo R Barja; Newton Santos de Faria Junior; Luís Vicente F de Oliveira; Luiz C de Mattos
Journal:  Arch Med Sci       Date:  2011-05-17       Impact factor: 3.318

3.  Histo-blood group gene polymorphisms as potential genetic modifiers of infection and cystic fibrosis lung disease severity.

Authors:  Jennifer L Taylor-Cousar; Maimoona A Zariwala; Lauranell H Burch; Rhonda G Pace; Mitchell L Drumm; Hollin Calloway; Haiying Fan; Brent W Weston; Fred A Wright; Michael R Knowles
Journal:  PLoS One       Date:  2009-01-26       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.